Published in
Elsevier, Reumatología Clínica, 4(13), p. 201-209
DOI: 10.1016/j.reuma.2016.04.010
Elsevier, Reumatología Clínica (English Edition), 4(13), p. 201-209
DOI: 10.1016/j.reumae.2016.04.015
Links
Tools
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of Latin American patients with rheumatoid arthritis: Pooled efficacy and safety analyses of Phase 3 and long-term extension studies
Journal article published in 2017 by
Sebastião Cezar Radominski,
Mario Humberto Cardiel,
Gustavo Citera,
Annelise Goecke,
Juan Jose Jaller,
Andrea Barranjard Vannucci Lomonte,
Pedro Miranda,
Patricia Velez,
Daniel Xibillé 
,
Kenneth Kwok,
Ricardo Rojo,
Erika Gabriela García
,
Kenneth Kwok,
Ricardo Rojo,
Erika Gabriela García
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 